BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37773324)

  • 1. Amide proton transfer imaging-arterial spin labeling mismatch: a new imaging biomarker for pilocytic astrocytoma.
    Rajendran A; Natesan C; Jawahar P; Patil S; Chilukuri S; Ghosh S; Kumar R; Jalali R
    Sci Rep; 2023 Sep; 13(1):16377. PubMed ID: 37773324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining amide proton transfer-weighted and arterial spin labeling imaging to differentiate solitary brain metastases from glioblastomas.
    Chen L; Li T; Li Y; Zhang J; Li S; Zhu L; Qin J; Tang L; Zeng Z
    Magn Reson Imaging; 2023 Oct; 102():96-102. PubMed ID: 37172748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High accuracy of arterial spin labeling perfusion imaging in differentiation of pilomyxoid from pilocytic astrocytoma.
    Nabavizadeh SA; Assadsangabi R; Hajmomenian M; Santi M; Vossough A
    Neuroradiology; 2015 May; 57(5):527-33. PubMed ID: 25666232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Gradient-Echo-Based Amide Proton Transfer-Weighted Imaging of Brain Tumors: Comparison With Two-Dimensional Spin-Echo-Based Amide Proton Transfer-Weighted Imaging.
    Murayama K; Ohno Y; Yui M; Yamamoto K; Ikedo M; Ohba S; Hanamatsu S; Iwase A; Ikeda H; Hirose Y; Toyama H
    J Comput Assist Tomogr; 2023 May-Jun 01; 47(3):494-499. PubMed ID: 37185016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Discrepancy between Arterial Spin Labeling Images and Contrast-enhanced Images in the Diagnosis of Brain Tumors.
    Abe T; Mizobuchi Y; Sako W; Irahara S; Otomi Y; Obama Y; Nakajima K; Khashbat D; Majigsuren M; Kageji T; Nagahiro S; Harada M
    Magn Reson Med Sci; 2015; 14(4):313-9. PubMed ID: 26104074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
    Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
    Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the Grading Accuracy of Astrocytic Neoplasms Noninvasively by Combining Timing Information with Cerebral Blood Flow: A Multi-TI Arterial Spin-Labeling MR Imaging Study.
    Yang S; Zhao B; Wang G; Xiang J; Xu S; Liu Y; Zhao P; Pfeuffer J; Qian T
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2209-2216. PubMed ID: 27561831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amide proton transfer-weighted imaging of pediatric brainstem glioma and its predicted value for H3 K27 alteration.
    Cheng D; Zhuo Z; Zhang P; Qu L; Duan Y; Xu X; Xie C; Liu X; Haller S; Barkhof F; Zhang L; Liu Y
    Acta Radiol; 2023 Nov; 64(11):2922-2930. PubMed ID: 37722801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas.
    Huang Q; Wu J; Le N; Shen Y; Guo P; Schreck KC; Kamson D; Blair L; Heo HY; Li X; Li W; Sair HL; Blakeley JO; Laterra J; Holdhoff M; Grossman SA; Mukherjee D; Bettegowda C; van Zijl P; Zhou J; Jiang S
    Magn Reson Imaging; 2023 Oct; 102():222-228. PubMed ID: 37321378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of amide proton transfer-weighted signals in the brain according to clinical condition and anatomical location.
    Lee JB; Park JE; Jung SC; Jo Y; Kim D; Kim HS; Choi CG; Kim SJ; Kang DW
    Eur Radiol; 2020 Jan; 30(1):346-356. PubMed ID: 31338651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
    Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
    BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?
    Yu H; Wen X; Wu P; Chen Y; Zou T; Wang X; Jiang S; Zhou J; Wen Z
    Eur Radiol; 2019 Oct; 29(10):5298-5306. PubMed ID: 30887206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors.
    Zhou J; Zaiss M; Knutsson L; Sun PZ; Ahn SS; Aime S; Bachert P; Blakeley JO; Cai K; Chappell MA; Chen M; Gochberg DF; Goerke S; Heo HY; Jiang S; Jin T; Kim SG; Laterra J; Paech D; Pagel MD; Park JE; Reddy R; Sakata A; Sartoretti-Schefer S; Sherry AD; Smith SA; Stanisz GJ; Sundgren PC; Togao O; Vandsburger M; Wen Z; Wu Y; Zhang Y; Zhu W; Zu Z; van Zijl PCM
    Magn Reson Med; 2022 Aug; 88(2):546-574. PubMed ID: 35452155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B
    Kanazawa Y; Fushimi Y; Sakashita N; Okada T; Arakawa Y; Miyazaki M
    Magn Reson Med Sci; 2018 Jan; 17(1):86-94. PubMed ID: 28566586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid suppression in amide proton transfer-weighted (APTw) CEST imaging: New theoretical insights and clinical benefits.
    Schüre JR; Casagranda S; Sedykh M; Liebig P; Papageorgakis C; Mancini L; Bisdas S; Nichelli L; Pinter N; Mechtler L; Jafari R; Boddaert N; Dangouloff-Ros V; Poujol J; Schmidt M; Doerfler A; Zaiss M
    Magn Reson Med; 2024 Apr; 91(4):1354-1367. PubMed ID: 38073061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric astrocytic tumor grading: comparison between arterial spin labeling and dynamic susceptibility contrast MRI perfusion.
    Morana G; Tortora D; Staglianò S; Nozza P; Mascelli S; Severino M; Piatelli G; Consales A; Lequin M; Garrè ML; Rossi A
    Neuroradiology; 2018 Apr; 60(4):437-446. PubMed ID: 29453753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
    Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
    Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging.
    Ho CY; Supakul N; Patel PU; Seit V; Groswald M; Cardinal J; Lin C; Kralik SF
    Neuroradiology; 2020 Jan; 62(1):81-88. PubMed ID: 31676961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas.
    Schön S; Cabello J; Liesche-Starnecker F; Molina-Romero M; Eichinger P; Metz M; Karimov I; Preibisch C; Keupp J; Hock A; Meyer B; Weber W; Zimmer C; Pyka T; Yakushev I; Gempt J; Wiestler B
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1468-1475. PubMed ID: 31953672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.